Halozyme Therapeutics (Halozyme Therapeutics) Total Inventories : $127.6 Mil (As of Dec. 2023)

Halozyme Therapeutics Total Inventories Chart

Halozyme Therapeutics Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Total Inventories		Get a 7-Day Free Trial					29.36	60.75	53.91	100.12	127.60

Halozyme Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Inventories	Get a 7-Day Free Trial															100.12	107.52	132.41	128.92	127.60

Halozyme Therapeutics Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Halozyme Therapeutics  (NAS:HALO) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Halozyme Therapeutics's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2023 is

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Halozyme Therapeutics's Days Inventory for the three months ended in Dec. 2023 is calculated as:

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Halozyme Therapeutics's Inventory Turnover for the quarter that ended in Dec. 2023 is calculated as

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Halozyme Therapeutics's Inventory to Revenue for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Halozyme Therapeutics Total Inventories Related Terms

Thank you for viewing the detailed overview of Halozyme Therapeutics's Total Inventories provided by GuruFocus.com. Please click on the following links to see related term pages.

Halozyme Therapeutics (Halozyme Therapeutics) Business Description